West Pharmaceutical Services Inc
WST· NYSE
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2013 | Q2 2012 | Q2 2011 | Q2 2010 |
|---|---|---|---|---|
| Revenue | $344.50M | $324.80M | $307.90M | $281.80M |
| Net Income | $30.20M | $15.60M | $20.10M | $21.70M |
| EPS Diluted | $0.43 |
West Pharmaceutical Services Inc · CIK 105770 · Engraved from SEC EDGAR
| $0.45 |
| $0.57 |
| $0.62 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.